Actuate Therapeutics (ACTU) Total Liabilities (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Total Liabilities of $6.1 million for Q4 2025, down 33.67% year-over-year from $9.2 million in Q4 2024, and down 9.82% quarter-over-quarter from $6.8 million in Q3 2025.
Actuate Therapeutics (ACTU) Total Liabilities (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Total Liabilities for 3 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities fell 33.67% year-over-year to $6.1 million; the TTM figure through Dec 2025 stood at $6.1 million (down 33.67% YoY), while the FY2025 annual figure was $6.1 million, down 33.67% from the prior year.
- Total Liabilities eased to $6.1 million in Q4 2025 per ACTU's latest filing, from $6.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $21.8 million in Q2 2024 and bottomed at $6.1 million in Q4 2025.
- Historically, Total Liabilities has averaged $10.1 million across 3 years, with a median of $9.1 million in 2024.
- Annual changes were most pronounced in 2024 — Total Liabilities advanced 9.13% — and 2025, when it slumped 55.88%.
- Actuate Therapeutics' Total Liabilities stood at $8.4 million in 2023, then grew by 9.13% to $9.2 million in 2024, then plunged by 33.67% to $6.1 million in 2025.
- Business Quant data shows ACTU's Total Liabilities at $6.1 million in Q4 2025, $6.8 million in Q3 2025, and $9.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 4.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.11 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 9.62 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 8.90 Mn |
| Jun 30, 2024 | 21.81 Mn |
| Dec 31, 2023 | 8.44 Mn |